Alcolase is developing an enzyme-based technology designed to break down alcohol in the stomach before it is absorbed into the bloodstream.
Alcolase has raised €1.5M across 1 funding round from 5 investors, most recently a round in May 2026. Based in Copenhagen, Denmark; active in Healthtech. Data as of 7 Aug 2026.
Timing: too soon vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-05-18 | Other | €1.5M |
| Ada Ventures,Antler,Business Angels,Delphinus Venture Capital,Manigoff Invest |
| View deal → |
